Y Zeng, J Fan, Q Zhang, P C Wang, D J Tang, S C Zhon, X W Zheng, D P Liu
{"title":"中国血友病患者血清LAV/HTLV-III抗体检测","authors":"Y Zeng, J Fan, Q Zhang, P C Wang, D J Tang, S C Zhon, X W Zheng, D P Liu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Using ELISA, Western blots and immunofluorescence techniques, we identified seropositivity for lymphadenopathy-associated virus/human lymphotropic virus-III (LAV/HTLV-III) in 4 of 18 hemophiliacs and 1 AIDS patient. The four seropositive patients had received factor VIII prepared by Armour Company. The hemophiliacs are all asymptomatic. Given this documentation of introduction of LAV/HTLV-III into China, a national surveillance program is underway.</p>","PeriodicalId":77660,"journal":{"name":"AIDS research","volume":"2 Suppl 1 ","pages":"S147-9"},"PeriodicalIF":0.0000,"publicationDate":"1986-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.\",\"authors\":\"Y Zeng, J Fan, Q Zhang, P C Wang, D J Tang, S C Zhon, X W Zheng, D P Liu\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Using ELISA, Western blots and immunofluorescence techniques, we identified seropositivity for lymphadenopathy-associated virus/human lymphotropic virus-III (LAV/HTLV-III) in 4 of 18 hemophiliacs and 1 AIDS patient. The four seropositive patients had received factor VIII prepared by Armour Company. The hemophiliacs are all asymptomatic. Given this documentation of introduction of LAV/HTLV-III into China, a national surveillance program is underway.</p>\",\"PeriodicalId\":77660,\"journal\":{\"name\":\"AIDS research\",\"volume\":\"2 Suppl 1 \",\"pages\":\"S147-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1986-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
利用ELISA、Western blots和免疫荧光技术,我们在18例血友病患者中的4例和1例艾滋病患者中检测到淋巴结病相关病毒/人淋巴细胞病毒- iii (LAV/HTLV-III)血清阳性。4例血清阳性患者均接受阿玛公司制备的第八因子治疗。血友病患者都没有症状。鉴于这些将LAV/HTLV-III引入中国的文件,一项国家监测计划正在进行中。
Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
Using ELISA, Western blots and immunofluorescence techniques, we identified seropositivity for lymphadenopathy-associated virus/human lymphotropic virus-III (LAV/HTLV-III) in 4 of 18 hemophiliacs and 1 AIDS patient. The four seropositive patients had received factor VIII prepared by Armour Company. The hemophiliacs are all asymptomatic. Given this documentation of introduction of LAV/HTLV-III into China, a national surveillance program is underway.